The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Victory Value Institutional UIVAX
- NAV / 1-Day Return 20.34 / +0.39 %
- Total Assets 1.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.860%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 1.15%
- Turnover 69%
USD | NAV as of Mar 29, 2024 | 1-Day Return as of Mar 29, 2024, 12:14 AM GMT+0
Morningstar’s Analysis UIVAX
Will UIVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 2.24 | 27.4 Mil | Financial Services |
Merck & Co Inc | 2.20 | 26.9 Mil | Healthcare |
The Goldman Sachs Group Inc | 1.94 | 23.7 Mil | Financial Services |
Fairfax Financial Holdings Ltd | 1.88 | 23.0 Mil | Financial Services |
Vistra Corp | 1.79 | 21.9 Mil | Utilities |
Alphabet Inc Class A | 1.79 | 21.8 Mil | Communication Services |
Progressive Corp | 1.69 | 20.6 Mil | Financial Services |
Cash | 1.58 | 19.3 Mil | Cash and Equivalents |
Johnson & Johnson | 1.44 | 17.6 Mil | Healthcare |
Keurig Dr Pepper Inc | 1.38 | 16.8 Mil | Consumer Defensive |